Related Experiment Video

Updated: Sep 4, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.7K

New strategies for decision making in prostate cancer. The role of oncotypedx

C Toribio-Vázquez1, J Gómez Rivas2, Á Yebes1

  • 1Servicio de Urología, Hospital Universitario La Paz, Madrid, Spain.

Actas Urologicas Espanolas
|July 16, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

774
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.2K

Related Experiment Videos

Last Updated: Sep 4, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.7K
Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

774
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.2K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

442
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
442
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K

Articles linked to this work by shared authors, journal, and citation graph.

Bridging the PSMA PET/CT access gap in prostate cancer: evidence, barriers, and priorities for implementation.

World journal of urology·2026

Whole-pelvic Versus Prostate-only Radiotherapy in Clinically Node-negative High-Risk Localised Prostate Cancer: A Systematic Review and Meta-analysis with Reconstructed Individual-patient Data.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Recommendations for the prevention and treatment of adverse effects of intravesical BCG.

Actas urologicas espanolas·2026

The future of prostate cancer screening in the European Union: PRAISE-U project.

Actas urologicas espanolas·2026

Past and present of prostate cancer screening in the European Union.

Actas urologicas espanolas·2026

The role of focal therapy for localized prostate cancer: From diagnosis to ablation.

Actas urologicas espanolas·2026

Multidisciplinary Consensus on Improving the Care Pathway for Overactive Bladder from an Adherence Perspective: The claVHes Consensus.

Actas urologicas espanolas·2026

Trifecta and Pentafecta in HoLEP: predictors of functional success in a prospective multicentre cohort study.

Actas urologicas espanolas·2026

Performance of the Quadruple-D score versus other nephrolithometric tools in obese patients undergoing percutaneous nephrolithotomy.

Actas urologicas espanolas·2026

The role of stone composition in determining outcomes after percutaneous nephrolithotomy.

Actas urologicas espanolas·2026

Predicting success after retrograde intrarenal surgery for 10-20 mm renal stones: A comparison of scoring systems.

Actas urologicas espanolas·2026

Urinary incontinence after treatment for localized prostate cancer: A systematic review and meta-analysis.

Actas urologicas espanolas·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us